Diagnostic Kits/Data, narratives and tools produced by the Kits' sector: Difference between revisions

From Commons Based Research
Jump to navigation Jump to search
Line 63: Line 63:
|$3120
|$3120
|}
|}
== Alzheimer's ==
=== APOE ===
Late Onset Alzheimer's Diseas (LOAD, AD2)
At a glance:
{|
|-
|Gene
|APOE
|-
|Patent Holders
|Duke university -> Athena Diagnostics (2 method patents for Dx alzheimer’s, don’t claim sequence, Bilski could destabilize; one claiming a kit) see ref2 pB-6
|-
|Key Patents
|5508167, 5716828, 6027896
|-
|Other Patents
|
|-
|Licenses
|exclusive
|-
|US Test providers
|1*
|-
|Test
|ADmark® ApoE Genotype Analysis & Interpretation - Symptomatic ($475)
|-
|Test cost
|$475
|}
*'''notes'''
*: Cook-Deegan notes “penumbra effect” wrt Athena. Athena sublicensed APOE for DTC testing to Smart Genetics, but First Inventor on patent raised licensing complaints for ethical reasons ([2] B-16).  APOE also is a marker for cardiovascular disease; testing for which does not infringe the methods patents, see [2]B-8; http://snpedia.com/index.php/Alzheimer's_disease. Also 2 testing labs in Canada, McGill and Sunnybrook both offer APOE testing for AD for $100 & $120 respectively ref2 pB-8.


== template ==
== template ==

Revision as of 18:23, 23 November 2009

Types of inputs for kits

Genetic Diagnostic Case Studies

The following are summaries of IP and commercialization information of commercially available diagnostic kits. A subset of this list will be developed into more extensive case studies. The old spreadsheet form of this information is available here.

Breast and Ovarian Cancer

BRCA1

At a glance:

Gene BRCA1
Patent Holders Myriad Genetics
Key Patents 5753441, 6051379
Other Patents
Licenses exclusive
US Test providers 1
Test BRACAnalysis ($3120) - includes BRCA1 & BRCA2
Test cost $3120

BRCA2

At a glance:

Gene BRCA2
Patent Holders Myriad Genetics
Key Patents 5753441, 6051379
Other Patents
Licenses exclusive
US Test providers 1
Test BRACAnalysis ($3120) - includes BRCA1 & BRCA2
Test cost $3120


Alzheimer's

APOE

Late Onset Alzheimer's Diseas (LOAD, AD2) At a glance:

Gene APOE
Patent Holders Duke university -> Athena Diagnostics (2 method patents for Dx alzheimer’s, don’t claim sequence, Bilski could destabilize; one claiming a kit) see ref2 pB-6
Key Patents 5508167, 5716828, 6027896
Other Patents
Licenses exclusive
US Test providers 1*
Test ADmark® ApoE Genotype Analysis & Interpretation - Symptomatic ($475)
Test cost $475
  • notes
    Cook-Deegan notes “penumbra effect” wrt Athena. Athena sublicensed APOE for DTC testing to Smart Genetics, but First Inventor on patent raised licensing complaints for ethical reasons ([2] B-16). APOE also is a marker for cardiovascular disease; testing for which does not infringe the methods patents, see [2]B-8; http://snpedia.com/index.php/Alzheimer's_disease. Also 2 testing labs in Canada, McGill and Sunnybrook both offer APOE testing for AD for $100 & $120 respectively ref2 pB-8.

template

Empty table

Gene
Patent Holders
Key Patents
Other Patents
Licenses
US Test providers
Test
Test cost

Definition List

  • Patent Holders
    (exclusive licensee)
  • key patents
    5753441, 6051379,
  • products
    prod ($3120)

References

Main Page Diagnostic_Kits

Retrieved from "http://cyber.harvard.edu/commonsbasedresearch/?title=Diagnostic_Kits/Data,_narratives_and_tools_produced_by_the_Kits%27_sector&oldid=5400"